Tail suspension test does not detect antidepressant-like properties of atypical antipsychotics

Abstract

The purpose of this study was to investigate the potency of atypical antipsychotics (clozapine, olanzapine, amisulpride, quetiapine, aripiprazole, risperidone) to reduce immobility time and to increase the fighting power, and the number of fights in an automated version of the tail suspension test in C57BL/6J mice. Antidepressant drugs, citalopram and imipramine were tested for comparison. Olanzapine (0.125-5 mg/kg), amisulpride (0.5-2 mg/kg), quetiapine (0.25-2 mg/kg), aripiprazole (0.25-1 mg/kg), and risperidone (0.005-0.05 mg/kg) did not produce any antidepressant-like effect. Only clozapine (0.156-2.5 mg/kg), administered at a dose of 0.312 mg/kg, significantly increased the number of fight episodes. As expected, citalopram (20-40 mg/kg) and imipramine (10-30 mg/kg) dose dependently produced antidepressant-like activity in the same procedure. The effect of antipsychotics on spontaneous locomotor activity and MK-801-induced or d-amphetamine-induced hyperactivity, were also tested in CD-1 mice to confirm the active doses of these drugs in tests commonly used to predict antipsychotic-like activity. Careful screening of potential antipsychotics for their antidepressant effects is considered to be an important part of modern drug development. Our data suggest that the tail suspension test in mice may be relatively insensitive to antidepressant-like activity of atypical antipsychotic drugs with antidepressant properties confirmed by clinical trials.

Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity

“…Moreover, its potential adverse effects, i.e., the risk of causing catalepsy and sedation, were tested in the bar test and the spontaneous locomotor activity test, respectively (Table ). , …”

Antipsychotic, antidepressant, and cognitive-impairment properties of antipsychotics: rat profile and implications for behavioral and psychological symptoms of dementia

“…This antipsychotic is among the most effective in reducing suicidality, a parameter which is strongly connected to depressed mood (Meltzer 2012). Previous studies of clozapine in the FST have shown that it is also active under other experimental conditions (Chindo et al 2012) and, in a comparative study in mice, was the only antipsychotic that showed activity in the tail-suspension test (Wesolowska et al 2011). It therefore seems that clozapine’s mood-modulating effects are clearly measurable in pharmacological models, and this might provide a criterion by which to evaluate novel drugs at an early stage of drug discovery.…”

A Role for the PKC Signaling System in the Pathophysiology and Treatment of Mood Disorders: Involvement of a Functional Imbalance?

“…One of the most established behavioral rodent model of mania is based on the measurement of psychostimulantinduced hyperactivity, a behavior that is reproducibly attenuated by a number of treatments used in mania, including lithium, valproate, and antipsychotics [45,46]. Studies performed in this model have suggested that PKC could be involved in the modulation of manic-like behavior.…”